熊去氧胆酸联合腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症临床分析

doi:10.3969/j.issn.1672-5069.2016.05.027

Abstract

Cai Tingting, Wang Wei, Xie Xueling.. Application of ursodeoxycholic acid and ademetionine in the treatment of pregnant women with intrahepatic cholestasis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 610-611.

References

[1] 何灿丽. 妊娠期肝内胆汁淤积症早期诊断与治疗.南昌大学学报（医学版）,2014,54（7）:54-57.
[2] Perin E,Cacciaguerra G,Driul L,et al. Intrahepatic cholestasis of pregnancy:diagnosis and obstetric management. Minerva Ginecol,2010,62（2）:97-103.
[3] Ramani K,Tomasi M L,Yang H,et al. Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis. J Biol Chem,2012,287（43）:341-355.
[4] 陈泓,张琚芳,朱启英. 腺苷蛋氨酸联合熊去氧胆酸治疗妊娠期肝内胆汁淤积症的系统评价.中国循证医学杂志,2014,16（8）:991-998.
[5] Fang L,Xie D,Wu X,et al. Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells. PLoS One,2013,8（8）:344-346.
[6] 张俊丽. 熊去氧胆酸与思美泰治疗妊娠期肝内胆汁淤积症156例. 中国药业,2013,22（3）:87-88.
[7] 陈梅梅,范建高. 妊娠期肝内胆汁淤积症的诊断与治疗. 实用肝脏病杂志,2012,15（6）:490-492.
[8] 葛星,徐叶清,黄三唤,等. 妊娠期肝内胆汁淤积症对分娩结局影响的出生队列研究. 中华流行病学杂志,2016,37（2）:187-191.
[9] 谢江燕,唐国珍. 饮食疗法联合优思弗对妊娠期肝内胆汁淤积症患者母婴结局的影响. 检验医学与临床,2015,12（24）:3671-3672.
[10] 孔祥璐,郭晓霞. 中药联合熊去氧胆酸胶囊治疗原发性胆汁性肝硬化疗效系统评价. 实用肝脏病杂志,2015,18（4）:379-382.
[11] Wang S,Tang H,Chen G,et al. Effect of ursodeoxycholic acid administration after liver transplantation on serum liver tests and biliary complications:a randomized clinical trial. Digestion,2012,86（3）:208-217.
[12] 刘益群. 腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症临床疗效. 中国医药导刊,2014,16（10）:1332-1333.
[13] Marciniak B,Kimber Z,Leszczynska B,et al. Treatment of obstetric cholestasis with polyunsaturated phosphatidylcholine and ursodeoxycholic acid. Ginekol Pol,2011,82（1）:26-31.
[14] Boberg KM,Wisloff T,Kjollesdal KS,et al. Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid. Aliment Pharmacol Ther,2013,38（7）:794-803.
[15] 周凡,高冰心,王晓东,等. 熊去氧胆酸和S-腺苷蛋氨酸改善妊娠肝内胆汁淤积症结局的系统评价. 中华肝脏病杂志,2014,22（4）:299-304.

Application of ursodeoxycholic acid and ademetionine in the treatment of pregnant women with intrahepatic cholestasis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[2]	Tang Renyi, Hu Qunfeng, Peng Liqing.. Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(6): 860-863.
[3]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[4]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[5]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[6]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[7]	Liu Yingchuan, Zhao Pengcheng, You Ting, et al.. Changes of peripheral blood 25-（OH） 2-D3 levels and peripheral T lymphocyte subsets in patients with primary biliary cirrhosis receiving vitamin D supplementation and ursodeoxycholic acid treatment [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 907-910.
[8]	Liu Jinguo, Wang Baokui. Efficacy of Fufangbiejia Ruanganpian and ursodeoxycholic acid combination in the treatment of patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 340-343.
[9]	Li Min, Li Hong, Fu Zhiyue. Efficacy of adenosylmethionine combined with ursodeoxycholic acid in treatment of infants with cytomegalovirus infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 461-462.
[10]	Sun Lin, Wang Dan, Wu Donghan. Impact of intrahepatic cholestasis of pregnancyon the outcomes of infants [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 133-134.
[11]	Liu Funa, Liu Jiangkui, Shen Yihui.. Efficacy of ursodeoxycholic acid and prednisolone combination in treatment of patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 443-446.
[12]	Han Huijuan, Wang Tao. Risk factors of intrahepatic cholestasis of pregnancy in patients with hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 280-283.
[13]	Ke Yingyue，Cui Yingying，Li Quanlun，et al.. Changes of serum biochemical indexes and its impact on perinatal prognosis of neonates in mothers with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 187-190.
[14]	Jiang Hao, Ge Hongyan.. Clinical efficacy of ursodeoxycholic acid combined with fat-soluble vitamin in treatment of patients with alcoholic liver disease and intrahepatic cholestasis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 105-106.
[15]	Guo Rui, Tan Jin.. A randomized controlled trial of ursodeoxycholic acid in treating patients with primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 109-110.